Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma

Purpose: To assess the safety and efficacy of a ciliary neurotrophic factor (CNTF) intraocular implant on neuroprotection and neuroenhancement in glaucoma. Design: Open-label, prospective, phase I clinical trial. Participants: A total of 11 participants were diagnosed with primary open-angle glaucom...

詳細記述

書誌詳細

出版年:	Ophthalmology Science
主要な著者:	Jeffrey L. Goldberg, MD, PhD, Gala Beykin, MD, Kellie R. Satterfield, MD, Mariana Nuñez, MD, Byron L. Lam, MD, Thomas A. Albini, MD
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2023-09-01
主題:	Glaucoma Neuroprotection Neuroenhancement Neurotrophic factor
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2666914523000301